Astellas Pharma has announced the appintment of a new Chief Medical Officer (CMO)- Dr Tadaaki Taniguchi, as of October 1, 2022. He joined Astellas as Executive Advisor on July 1, 2022.

He is an internationally trained surgeon in the field of oncology with extensive industry experience in developing and commercializing innovative medicines as a senior leader in major global pharmaceutical companies.  He will be based in the US.

The firm has also announced the appointment of CPO and CECO. The name of Chief Administrative Officer and Chief Ethics & Compliance Officer (CAO & CECO) will be renamed to the Chief People Officer and Chief Ethics & Compliance Officer (CPO & CECO). With the growing focus on human capital in corporate management, the change signifies this position's leadership role in transforming human resources and the organization as a whole. Katsuyoshi Sugita will be appointed to CPO & CECO. He has held senior HR leadership positions in the pharmaceutical and technology industries and joined Astellas as Head of Human Resources in May 2021.